Healthcare Stock to Watch: Diabetes Player Insulet

TL;DR

Insulet, a company making tubeless insulin pumps, faces competition but shows growth potential in the diabetes market.

Transcript

Shannon Jones: Let's dive into your first one. This is a stock that one of our fellow colleagues, Brian Feroldi, has talked quite a bit about. Tell us about your first top healthcare pick. Todd Campbell: We've talked in the past on the show a lot about diabetes and what a major market opportunity that is for investors. One of the companies that I w... Read More

Key Insights

• 🏪 Insulet's tubeless insulin pump offers convenience and automated insulin delivery for diabetes patients.
• 🎁 The diabetes market presents a significant opportunity for companies like Insulet to innovate and improve treatment.
• 🧘 Competition from industry giants like Medtronic and Tandem challenges Insulet's market position.
• 🚚 Insulet's projected growth reflects its ability to navigate competition and deliver innovative solutions.
• 😨 Partnerships with companies like Amgen showcase Insulet's potential for expansion beyond diabetes care.
• 🍉 Insulet's focus on profitability and expense control highlights its commitment to long-term success.
• ❓ The introduction of an automated system by Insulet in 2020 could further differentiate the company in the market.

Questions & Answers

Q: What sets Insulet apart in the diabetes market?

Insulet's tubeless insulin pump offers convenience and automated insulin delivery, catering to the needs of diabetes patients for easier insulin management.

Q: How does Insulet plan to compete with industry giants like Medtronic and Tandem?

Insulet is developing its own automated system set to launch in 2020, focusing on convenience and smartphone integration, positioning itself for continued growth.

Q: What growth prospects does Insulet have in the expanding diabetes market?

With the diabetes population projected to grow, Insulet's innovative devices and partnerships with companies like Amgen underscore its potential in the healthcare sector.

Summary & Key Takeaways

• Insulet creates tubeless insulin pumps for diabetes patients, with potential for expansion beyond diabetes.

• The diabetes market is vast, with Insulet's innovative devices simplifying insulin delivery.

• Insulet faces competition from Medtronic and Tandem but is poised for growth and profitability.